These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16571954)

  • 21. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].
    Sparr HJ; Booij LH; Fuchs-Buder T
    Anaesthesist; 2009 Jan; 58(1):66-80. PubMed ID: 19082568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
    Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sugammadex in patients with myasthenia gravis.
    De Boer HD; Van Egmond J; Driessen JJ; Booij LHJD
    Anaesthesia; 2010 Jun; 65(6):653. PubMed ID: 20565409
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sugammadex, a novel drug for neuromuscular blockade reversal].
    Fernández Meré LA; Alvarez-Blanco M
    Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
    Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
    J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.
    de Boer HD; Driessen JJ; van Egmond J; Booij LH
    Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of rocuronium and sugammadex in rapid sequence induction in pregnancy.
    McGuigan PJ; Shields MO; McCourt KC
    Br J Anaesth; 2011 Mar; 106(3):418-9; author reply 419-20. PubMed ID: 21317233
    [No Abstract]   [Full Text] [Related]  

  • 32. Sugammadex is effective in reversing rocuronium in the presence of antibiotics.
    Hudson ME; Rietbergen H; Chelly JE
    BMC Anesthesiol; 2014; 14():69. PubMed ID: 25157214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sugammadex: a review of its use in anaesthetic practice.
    Yang LP; Keam SJ
    Drugs; 2009; 69(7):919-42. PubMed ID: 19441874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected failure of rocuronium-mediated neuromuscular blockade.
    Harris P
    Anaesthesia; 2011 Jun; 66(6):525; author reply 525-6. PubMed ID: 21568992
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of magnesium sulphate on sugammadex reversal time for neuromuscular blockade: a randomised controlled study.
    Germano Filho PA; Cavalcanti IL; Barrucand L; Verçosa N
    Anaesthesia; 2015 Aug; 70(8):956-61. PubMed ID: 25829048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).
    Molina AL; de Boer HD; Klimek M; Heeringa M; Klein J
    Br J Anaesth; 2007 May; 98(5):624-7. PubMed ID: 17347184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
    Pühringer FK; Kristen P; Rex C
    Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.